• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD 6.90% 2.7¢

ADALTA LIMITED - Announcements

AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company... AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II clinical trials with applications in the fields of inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic for the treatment of fibrotic diseases, including lung fibrosis (specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD)), kidney fibrosis, eye fibrosis and some cancers. Chimeric Antigen Receptor (CAR) cell therapies involve modification of a patient’s immune cells (T cells, NK cells, macrophages and other) so that they produce a CAR on the cell surface that enables the patient’s immune system to recognize and kill diseased cells such as cancer. It develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology. It evaluates several CXCR4 i-bodies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


1AD Application for quotation of securities - 1AD01/05/24 download Created with Sketch. 15.38KB
1AD Investor webinar presentation01/05/24 download Created with Sketch. 2.7MB
1AD Application for quotation of securities - 1AD30/04/24 download Created with Sketch. 18.02KB
1AD Investor webinar30/04/24 download Created with Sketch. 183.46KB
1AD Cleansing Notice under Section 708A29/04/24 download Created with Sketch. 266.97KB
1AD Cleansing Notice under Section 708A29/04/24 download Created with Sketch. 265.46KB
1AD Extension of Victorian Government RDTI Loan FacilityPRICE SENSITIVE29/04/24 download Created with Sketch. 157.33KB
1AD Institutional investment to pursue strategic initiativesPRICE SENSITIVE29/04/24 download Created with Sketch. 227.72KB
1AD Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE29/04/24 download Created with Sketch. 329.99KB
1AD Proposed issue of securities - 1AD29/04/24 download Created with Sketch. 16.3KB
1AD Proposed issue of securities - 1AD29/04/24 download Created with Sketch. 18.03KB
1AD Application for quotation of securities - 1AD29/04/24 download Created with Sketch. 16.25KB
1AD Notification of Expiry of Listed Options24/04/24 download Created with Sketch. 643.26KB
1AD SYNBV MoU Webinar presentationPRICE SENSITIVE10/04/24 download Created with Sketch. 2.48MB
1AD Webinar to discuss SYNthesis BioVentures partnership08/04/24 download Created with Sketch. 184.28KB
1AD SYNThesis BioVentures MoU for cellular immunotherapiesPRICE SENSITIVE08/04/24 download Created with Sketch. 211.2KB
1AD AdAlta presenting at ASX Gems conference20/03/24 download Created with Sketch. 166.73KB
1AD Application for quotation of securities - 1AD15/03/24 download Created with Sketch. 15.38KB
1AD Corporate PresentationPRICE SENSITIVE08/03/24 download Created with Sketch. 6.77MB
1AD Share Cafe webinar on Phase I results07/03/24 download Created with Sketch. 147.32KB
1AD Positive AD-214 Phase I extension study resultsPRICE SENSITIVE06/03/24 download Created with Sketch. 348.79KB
1AD Half Yearly Report and AccountsPRICE SENSITIVE27/02/24 download Created with Sketch. 2.25MB
1AD Australia Biologics Festival Presentation20/02/24 download Created with Sketch. 7.4MB
1AD Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 535.77KB
1AD January 2024 partnering presentations and progressPRICE SENSITIVE22/01/24 download Created with Sketch. 3.56MB
1AD Notification regarding unquoted securities - 1AD10/01/24 download Created with Sketch. 26.93KB
1AD Change of Director's Interest Notice (TO)20/12/23 download Created with Sketch. 241.35KB
1AD New malaria inhibiting i-bodyPRICE SENSITIVE19/12/23 download Created with Sketch. 183.61KB
1AD Application for quotation of securities - 1AD19/12/23 download Created with Sketch. 24.69KB
1AD Application for quotation of securities - 1AD19/12/23 download Created with Sketch. 26.96KB
1AD Application for quotation of securities - 1AD19/12/23 download Created with Sketch. 24.7KB
1AD Change of Director's Interest Notice x 4 (TO, PM, DF & RP)19/12/23 download Created with Sketch. 419.64KB
1AD AdAlta launches new InvestorHub18/12/23 download Created with Sketch. 175.72KB
1AD Results of Meeting14/12/23 download Created with Sketch. 180.25KB
1AD Chair address to EGM14/12/23 download Created with Sketch. 168.12KB
1AD Investor Webinar Presentation23/11/23 download Created with Sketch. 146.6KB
1AD Results of Meeting22/11/23 download Created with Sketch. 162.11KB
1AD Chair address and CEO presentation to AGMPRICE SENSITIVE22/11/23 download Created with Sketch. 7.14MB
1AD AD-214 Phase I extension clinical study - interim resultsPRICE SENSITIVE21/11/23 download Created with Sketch. 175.87KB
1AD Becoming a substantial holder20/11/23 download Created with Sketch. 344.19KB
1AD Change in substantial holding16/11/23 download Created with Sketch. 153.84KB
1AD Letter to Shareholders, Notice of EGM & Proxy Form15/11/23 download Created with Sketch. 549.11KB
1AD Application for quotation of securities - 1AD14/11/23 download Created with Sketch. 26.86KB
1AD Update - Proposed issue of securities - 1AD09/11/23 download Created with Sketch. 27.4KB
1AD Update - Proposed issue of securities - 1AD09/11/23 download Created with Sketch. 25.4KB
1AD Proposed issue of securities - 1AD09/11/23 download Created with Sketch. 27.05KB
1AD Proposed issue of securities - 1AD09/11/23 download Created with Sketch. 24.78KB
1AD Oversubscribed placement resultPRICE SENSITIVE07/11/23 download Created with Sketch. 324.5KB
1AD Proposed issue of securities - 1AD03/11/23 download Created with Sketch. 27.42KB
1AD Proposed issue of securities - 1AD03/11/23 download Created with Sketch. 25.59KB
1AD ProspectusPRICE SENSITIVE03/11/23 download Created with Sketch. 620.56KB
1AD Placement to raise up to $1.23millionPRICE SENSITIVE03/11/23 download Created with Sketch. 343.28KB
1AD Trading HaltPRICE SENSITIVE03/11/23 download Created with Sketch. 387.05KB
1AD Investor PresentationPRICE SENSITIVE27/10/23 download Created with Sketch. 7.24MB
1AD Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE27/10/23 download Created with Sketch. 417.17KB
1AD AD-214 well tolerated in Phase I extension studyPRICE SENSITIVE23/10/23 download Created with Sketch. 343.23KB
1AD Letter to Shareholders, Notice of AGM & Proxy Form20/10/23 download Created with Sketch. 1.28MB
1AD AD-214 oral presentation at MPGPCR2319/10/23 download Created with Sketch. 358.96KB
1AD R&D tax refund received & R&D Loan repayment terms extendedPRICE SENSITIVE18/10/23 download Created with Sketch. 214.24KB
1AD Investor roadshow with IPF survivor Bill van Nierop13/10/23 download Created with Sketch. 360.15KB
1AD Notification regarding unquoted securities - 1AD12/10/23 download Created with Sketch. 25.01KB
1AD Notification of cessation of securities - 1AD12/10/23 download Created with Sketch. 21.54KB
1AD Cleansing Notice under Section 708A27/09/23 download Created with Sketch. 344.17KB
1AD Application for quotation of securities - 1AD27/09/23 download Created with Sketch. 25.32KB
1AD Prof Foley invited presentation AD-214PRICE SENSITIVE26/09/23 download Created with Sketch. 11.02MB
1AD Dosing simulations support AD-214 IV product profilePRICE SENSITIVE25/09/23 download Created with Sketch. 2.19MB
1AD Notification of Date of 2023 AGM22/09/23 download Created with Sketch. 232.34KB
1AD AD-214 Phase I extension study fully enrolledPRICE SENSITIVE20/09/23 download Created with Sketch. 215.38KB
1AD Appendix 4G and Corporate Governance Statement25/08/23 download Created with Sketch. 589.46KB
1AD Annual Report to shareholders25/08/23 download Created with Sketch. 1.29MB
1AD Preliminary Final ReportPRICE SENSITIVE25/08/23 download Created with Sketch. 416.83KB
1AD Investor webinar - recent AD-214 progress07/08/23 download Created with Sketch. 336.87KB
1AD AD-214 returns to clinicPRICE SENSITIVE04/08/23 download Created with Sketch. 387.83KB
1AD Change in substantial holding21/07/23 download Created with Sketch. 142.13KB
1AD Change in substantial holding14/07/23 download Created with Sketch. 152.92KB
1AD Notification of cessation of securities - 1AD14/07/23 download Created with Sketch. 21.54KB
1AD Cleansing Notice under Section 708A13/07/23 download Created with Sketch. 310.36KB
1AD Application for quotation of securities - 1AD13/07/23 download Created with Sketch. 26.58KB
1AD Application for quotation of securities - 1AD13/07/23 download Created with Sketch. 24.7KB
1AD Investor PresentationPRICE SENSITIVE13/07/23 download Created with Sketch. 6.08MB
1AD $1.87 million raised in oversubscribed Shortfall facilityPRICE SENSITIVE13/07/23 download Created with Sketch. 757.53KB
1AD Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE13/07/23 download Created with Sketch. 553.96KB
1AD New AD-214 data de-risks clinical studiesPRICE SENSITIVE07/07/23 download Created with Sketch. 576.07KB
1AD AD-214 clinical trial approvalPRICE SENSITIVE29/06/23 download Created with Sketch. 308.02KB
1AD Change in substantial holding31/05/23 download Created with Sketch. 142.35KB
1AD Change in substantial holding31/05/23 download Created with Sketch. 156.65KB
1AD Change of Director's Interest Notice x 2 (TO & DF)31/05/23 download Created with Sketch. 305.02KB
1AD Top 20 Option Holders & Distribution Schedule29/05/23 download Created with Sketch. 87.81KB
1AD Application for quotation of securities - 1AD29/05/23 download Created with Sketch. 26.91KB
1AD Investor Summit live and recorded presentation29/05/23 download Created with Sketch. 261.41KB
1AD Investor presentation25/05/23 download Created with Sketch. 5.15MB
1AD Rights Offer resultsPRICE SENSITIVE25/05/23 download Created with Sketch. 311.86KB
1AD Notice of change of exercise price of options22/05/23 download Created with Sketch. 268.69KB
1AD Despatch of Rights Offer documentation08/05/23 download Created with Sketch. 263.88KB
1AD Investor Presentation - Rights Offer Webinar03/05/23 download Created with Sketch. 5.26MB
1AD Letter to Ineligible Foreign Shareholders28/04/23 download Created with Sketch. 200.42KB
1AD Application for quotation of securities - 1AD28/04/23 download Created with Sketch. 29.37KB
1AD Letter to Eligible Shareholders28/04/23 download Created with Sketch. 339.27KB
1AD Letter to Optionholders28/04/23 download Created with Sketch. 332.74KB
1AD Target Market Determination28/04/23 download Created with Sketch. 188.19KB
1AD Application for quotation of securities - 1AD
01/05/24 download Created with Sketch. 15.38KB
1AD Investor webinar presentation
01/05/24 download Created with Sketch. 2.7MB
1AD Application for quotation of securities - 1AD
30/04/24 download Created with Sketch. 18.02KB
1AD Investor webinar
30/04/24 download Created with Sketch. 183.46KB
1AD Cleansing Notice under Section 708A
29/04/24 download Created with Sketch. 266.97KB
1AD Cleansing Notice under Section 708A
29/04/24 download Created with Sketch. 265.46KB
1AD Extension of Victorian Government RDTI Loan Facility
29/04/24PRICE SENSITIVE download Created with Sketch. 157.33KB
1AD Institutional investment to pursue strategic initiatives
29/04/24PRICE SENSITIVE download Created with Sketch. 227.72KB
1AD Quarterly Appendix 4C and Activities Report
29/04/24PRICE SENSITIVE download Created with Sketch. 329.99KB
1AD Proposed issue of securities - 1AD
29/04/24 download Created with Sketch. 16.3KB
1AD Proposed issue of securities - 1AD
29/04/24 download Created with Sketch. 18.03KB
1AD Application for quotation of securities - 1AD
29/04/24 download Created with Sketch. 16.25KB
1AD Notification of Expiry of Listed Options
24/04/24 download Created with Sketch. 643.26KB
1AD SYNBV MoU Webinar presentation
10/04/24PRICE SENSITIVE download Created with Sketch. 2.48MB
1AD Webinar to discuss SYNthesis BioVentures partnership
08/04/24 download Created with Sketch. 184.28KB
1AD SYNThesis BioVentures MoU for cellular immunotherapies
08/04/24PRICE SENSITIVE download Created with Sketch. 211.2KB
1AD AdAlta presenting at ASX Gems conference
20/03/24 download Created with Sketch. 166.73KB
1AD Application for quotation of securities - 1AD
15/03/24 download Created with Sketch. 15.38KB
1AD Corporate Presentation
08/03/24PRICE SENSITIVE download Created with Sketch. 6.77MB
1AD Share Cafe webinar on Phase I results
07/03/24 download Created with Sketch. 147.32KB
1AD Positive AD-214 Phase I extension study results
06/03/24PRICE SENSITIVE download Created with Sketch. 348.79KB
1AD Half Yearly Report and Accounts
27/02/24PRICE SENSITIVE download Created with Sketch. 2.25MB
1AD Australia Biologics Festival Presentation
20/02/24 download Created with Sketch. 7.4MB
1AD Quarterly Appendix 4C and Activities Report
31/01/24PRICE SENSITIVE download Created with Sketch. 535.77KB
1AD January 2024 partnering presentations and progress
22/01/24PRICE SENSITIVE download Created with Sketch. 3.56MB
1AD Notification regarding unquoted securities - 1AD
10/01/24 download Created with Sketch. 26.93KB
1AD Change of Director's Interest Notice (TO)
20/12/23 download Created with Sketch. 241.35KB
1AD New malaria inhibiting i-body
19/12/23PRICE SENSITIVE download Created with Sketch. 183.61KB
1AD Application for quotation of securities - 1AD
19/12/23 download Created with Sketch. 24.69KB
1AD Application for quotation of securities - 1AD
19/12/23 download Created with Sketch. 26.96KB
1AD Application for quotation of securities - 1AD
19/12/23 download Created with Sketch. 24.7KB
1AD Change of Director's Interest Notice x 4 (TO, PM, DF & RP)
19/12/23 download Created with Sketch. 419.64KB
1AD AdAlta launches new InvestorHub
18/12/23 download Created with Sketch. 175.72KB
1AD Results of Meeting
14/12/23 download Created with Sketch. 180.25KB
1AD Chair address to EGM
14/12/23 download Created with Sketch. 168.12KB
1AD Investor Webinar Presentation
23/11/23 download Created with Sketch. 146.6KB
1AD Results of Meeting
22/11/23 download Created with Sketch. 162.11KB
1AD Chair address and CEO presentation to AGM
22/11/23PRICE SENSITIVE download Created with Sketch. 7.14MB
1AD AD-214 Phase I extension clinical study - interim results
21/11/23PRICE SENSITIVE download Created with Sketch. 175.87KB
1AD Becoming a substantial holder
20/11/23 download Created with Sketch. 344.19KB
1AD Change in substantial holding
16/11/23 download Created with Sketch. 153.84KB
1AD Letter to Shareholders, Notice of EGM & Proxy Form
15/11/23 download Created with Sketch. 549.11KB
1AD Application for quotation of securities - 1AD
14/11/23 download Created with Sketch. 26.86KB
1AD Update - Proposed issue of securities - 1AD
09/11/23 download Created with Sketch. 27.4KB
1AD Update - Proposed issue of securities - 1AD
09/11/23 download Created with Sketch. 25.4KB
1AD Proposed issue of securities - 1AD
09/11/23 download Created with Sketch. 27.05KB
1AD Proposed issue of securities - 1AD
09/11/23 download Created with Sketch. 24.78KB
1AD Oversubscribed placement result
07/11/23PRICE SENSITIVE download Created with Sketch. 324.5KB
1AD Proposed issue of securities - 1AD
03/11/23 download Created with Sketch. 27.42KB
1AD Proposed issue of securities - 1AD
03/11/23 download Created with Sketch. 25.59KB
1AD Prospectus
03/11/23PRICE SENSITIVE download Created with Sketch. 620.56KB
1AD Placement to raise up to $1.23million
03/11/23PRICE SENSITIVE download Created with Sketch. 343.28KB
1AD Trading Halt
03/11/23PRICE SENSITIVE download Created with Sketch. 387.05KB
1AD Investor Presentation
27/10/23PRICE SENSITIVE download Created with Sketch. 7.24MB
1AD Quarterly Appendix 4C and Activities Report
27/10/23PRICE SENSITIVE download Created with Sketch. 417.17KB
1AD AD-214 well tolerated in Phase I extension study
23/10/23PRICE SENSITIVE download Created with Sketch. 343.23KB
1AD Letter to Shareholders, Notice of AGM & Proxy Form
20/10/23 download Created with Sketch. 1.28MB
1AD AD-214 oral presentation at MPGPCR23
19/10/23 download Created with Sketch. 358.96KB
1AD R&D tax refund received & R&D Loan repayment terms extended
18/10/23PRICE SENSITIVE download Created with Sketch. 214.24KB
1AD Investor roadshow with IPF survivor Bill van Nierop
13/10/23 download Created with Sketch. 360.15KB
1AD Notification regarding unquoted securities - 1AD
12/10/23 download Created with Sketch. 25.01KB
1AD Notification of cessation of securities - 1AD
12/10/23 download Created with Sketch. 21.54KB
1AD Cleansing Notice under Section 708A
27/09/23 download Created with Sketch. 344.17KB
1AD Application for quotation of securities - 1AD
27/09/23 download Created with Sketch. 25.32KB
1AD Prof Foley invited presentation AD-214
26/09/23PRICE SENSITIVE download Created with Sketch. 11.02MB
1AD Dosing simulations support AD-214 IV product profile
25/09/23PRICE SENSITIVE download Created with Sketch. 2.19MB
1AD Notification of Date of 2023 AGM
22/09/23 download Created with Sketch. 232.34KB
1AD AD-214 Phase I extension study fully enrolled
20/09/23PRICE SENSITIVE download Created with Sketch. 215.38KB
1AD Appendix 4G and Corporate Governance Statement
25/08/23 download Created with Sketch. 589.46KB
1AD Annual Report to shareholders
25/08/23 download Created with Sketch. 1.29MB
1AD Preliminary Final Report
25/08/23PRICE SENSITIVE download Created with Sketch. 416.83KB
1AD Investor webinar - recent AD-214 progress
07/08/23 download Created with Sketch. 336.87KB
1AD AD-214 returns to clinic
04/08/23PRICE SENSITIVE download Created with Sketch. 387.83KB
1AD Change in substantial holding
21/07/23 download Created with Sketch. 142.13KB
1AD Change in substantial holding
14/07/23 download Created with Sketch. 152.92KB
1AD Notification of cessation of securities - 1AD
14/07/23 download Created with Sketch. 21.54KB
1AD Cleansing Notice under Section 708A
13/07/23 download Created with Sketch. 310.36KB
1AD Application for quotation of securities - 1AD
13/07/23 download Created with Sketch. 26.58KB
1AD Application for quotation of securities - 1AD
13/07/23 download Created with Sketch. 24.7KB
1AD Investor Presentation
13/07/23PRICE SENSITIVE download Created with Sketch. 6.08MB
1AD $1.87 million raised in oversubscribed Shortfall facility
13/07/23PRICE SENSITIVE download Created with Sketch. 757.53KB
1AD Quarterly Appendix 4C and Activities Report
13/07/23PRICE SENSITIVE download Created with Sketch. 553.96KB
1AD New AD-214 data de-risks clinical studies
07/07/23PRICE SENSITIVE download Created with Sketch. 576.07KB
1AD AD-214 clinical trial approval
29/06/23PRICE SENSITIVE download Created with Sketch. 308.02KB
1AD Change in substantial holding
31/05/23 download Created with Sketch. 142.35KB
1AD Change in substantial holding
31/05/23 download Created with Sketch. 156.65KB
1AD Change of Director's Interest Notice x 2 (TO & DF)
31/05/23 download Created with Sketch. 305.02KB
1AD Top 20 Option Holders & Distribution Schedule
29/05/23 download Created with Sketch. 87.81KB
1AD Application for quotation of securities - 1AD
29/05/23 download Created with Sketch. 26.91KB
1AD Investor Summit live and recorded presentation
29/05/23 download Created with Sketch. 261.41KB
1AD Investor presentation
25/05/23 download Created with Sketch. 5.15MB
1AD Rights Offer results
25/05/23PRICE SENSITIVE download Created with Sketch. 311.86KB
1AD Notice of change of exercise price of options
22/05/23 download Created with Sketch. 268.69KB
1AD Despatch of Rights Offer documentation
08/05/23 download Created with Sketch. 263.88KB
1AD Investor Presentation - Rights Offer Webinar
03/05/23 download Created with Sketch. 5.26MB
1AD Letter to Ineligible Foreign Shareholders
28/04/23 download Created with Sketch. 200.42KB
1AD Application for quotation of securities - 1AD
28/04/23 download Created with Sketch. 29.37KB
1AD Letter to Eligible Shareholders
28/04/23 download Created with Sketch. 339.27KB
1AD Letter to Optionholders
28/04/23 download Created with Sketch. 332.74KB
1AD Target Market Determination
28/04/23 download Created with Sketch. 188.19KB
(20min delay)
Last
2.7¢
Change
-0.002(6.90%)
Mkt cap ! $14.38M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $9.445K 348.8K

Buyers (Bids)

No. Vol. Price($)
1 21405 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 681148 3
View Market Depth
Last trade - 13.13pm 03/05/2024 (20 minute delay) ?
Last
2.7¢
  Change
-0.002 ( 3.57 %)
Open High Low Volume
2.7¢ 2.7¢ 2.7¢ 269805
Last updated 13.13pm 03/05/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.